STYLAGE XL Lidocaine (2 x 1 ml)

STYLAGE

Aesthetic / Dermal Filler

Facial volume restoration & contouring

CE‑marked Class III medical device under Vivacy quality standards for injectable HA fillers. :contentReference[oaicite:28]{index=28}
Manufactured under IPN‑Like cross‑linking technology for improved gel stability and longevity. :contentReference[oaicite:29]{index=29}

CE‑marked Class III medical device under Vivacy quality standards for injectable HA fillers. :contentReference[oaicite:28]{index=28}
Manufactured under IPN‑Like cross‑linking technology for improved gel stability and longevity. :contentReference[oaicite:29]{index=29}

Facial volume restoration & contouring

Description

STYLAGE XL Lidocaine is a sterile, monophasic, antioxidant cross‑linked hyaluronic acid gel (IPN‑Like technology) with 26 mg/ml HA concentration and 0.3% lidocaine, intended for deep dermis or subcutaneous injection to restore lost facial volume, re‑contour facial structure, and correct deep wrinkles or skin sagging.

Bnefits

Restores lost facial volume and structural support (cheeks, chin, jawline, temples, cheeks) :contentReference[oaicite:0]{index=0}
Provides volumizing and lifting effect to correct sagging skin and facial hollows :contentReference[oaicite:1]{index=1}
Contains 0.3% lidocaine for increased injection comfort and reduced pain during treatment :contentReference[oaicite:2]{index=2}
Includes antioxidant mannitol to slow HA degradation and reduce post-injection inflammation and oxidative stress, improving gel longevity :contentReference[oaicite:3]{index=3}
Long‑lasting results — typically 12 to 18 months depending on treated area, skin, and patient factors :contentReference[oaicite:4]{index=4}

Indications

Facial volume restoration (cheeks, cheekbones, jawline, chin, temples) :contentReference[oaicite:5]{index=5}
Correction of facial hollows or fat loss (age‑related or due to lipodystrophy) :contentReference[oaicite:6]{index=6}
Reshaping and contouring of facial structure (face oval, chin, jawline) for a more youthful appearance :contentReference[oaicite:7]{index=7}
Treatment of deep wrinkles, folds or skin sagging, especially in thick skin or deep‑wrinkle patients :contentReference[oaicite:8]{index=8}
Optional: hand rejuvenation or volume restoration on hands or back of hands in case of fat loss/facial lipodystrophy according to some distributor sources :contentReference[oaicite:9]{index=9}

Composition

Cross‑linked hyaluronic acid (IPN‑Like) — 26 mg/ml HA gel :contentReference[oaicite:10]{index=10}
Mannitol (antioxidant) to protect HA from oxidative degradation and reduce post-injection inflammation :contentReference[oaicite:11]{index=11}
Lidocaine hydrochloride 0.3% (local anaesthetic) for injection comfort :contentReference[oaicite:12]{index=12}
Phosphate buffer (pH 7.2) and other excipients per manufacturer formulation :contentReference[oaicite:13]{index=13}

Formulation

Sterile, biodegradable monophasic cross-linked HA gel using IPN‑Like® Technology with antioxidant and local anaesthetic (lidocaine) additive (Bi‑SOFT formulation) :contentReference[oaicite:14]{index=14}

Packaging

2 × 1 ml pre-filled sterile syringes (glass, latex-free) with single-use needles (commonly 27G½ or 23G depending on distributor) :contentReference[oaicite:15]{index=15}

Usage

For use by qualified and trained medical professionals only. :contentReference[oaicite:16]{index=16}
Inject into deep dermis or subcutaneous layer depending on area treated, using appropriate injection technique (needle or cannula) to ensure even distribution. :contentReference[oaicite:17]{index=17}
Post‑treatment care: avoid extreme heat or cold, excessive sun exposure, strenuous exercise, and avoid massaging treated areas for initial 48–72 h, per distributor guidance. :contentReference[oaicite:18]{index=18}

Contraindications

Hypersensitivity to hyaluronic acid, lidocaine or any component of the formulation :contentReference[oaicite:21]{index=21}
Active skin infection, inflammation or lesions at injection site :contentReference[oaicite:22]{index=22}
Pregnancy or breastfeeding (use not recommended) :contentReference[oaicite:23]{index=23}
Use in minors under legal adult age or per local regulatory practice :contentReference[oaicite:24]{index=24}

Adverse Effects

Transient injection-site reactions: redness, swelling, bruising, tenderness, itching or firmness. :contentReference[oaicite:25]{index=25}
Rare but serious: risk of nodules, granulomas, vascular occlusion, or allergic reactions especially if improperly injected — requires experienced practitioner and emergency protocols (e.g. hyaluronidase) :contentReference[oaicite:26]{index=26}

Storage Conditions

Store between 2 °C and 25 °C, protect from freezing, excessive heat and direct sunlight; keep syringes sealed until use. :contentReference[oaicite:27]{index=27}

Duration

12\u201318 months (depending on treated area, skin type, metabolism, and technique) :contentReference[oaicite:19]{index=19}

Onset

Immediate volumizing/contour improvement visible upon injection; optimal aesthetic result after initial swelling subsides (usually within days) :contentReference[oaicite:20]{index=20}